Literature DB >> 19444578

Nociceptin receptor antagonist JTC-801 inhibits nitrous oxide-induced analgesia in mice.

Tomohiro Koyama1, Kazuhiko Fukuda.   

Abstract

The mechanism of the analgesic effect of nitrous oxide (N(2)O) has not been completely clarified. Although we have reported that the analgesic effect of N(2)O was significantly decreased in nociceptin-orphanin FQ (N/OFQ) receptor (NOP)-deficient mice, the effect of nociceptin receptor antagonists on N(2)O-induced analgesia has not been reported. In this investigation, we examined the effect of the NOP antagonist JTC-801 on N(2)O-induced analgesia in 129Sv mice by the writhing test and tail flick test, and demonstrated that the analgesic effect of N(2)O was suppressed by the intraperitoneal administration of JTC-801.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19444578     DOI: 10.1007/s00540-009-0739-2

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  17 in total

1.  The involvement of the nociceptin receptor in the antinociceptive action of nitrous oxide.

Authors:  Shugaku Himukashi; Hiroshi Takeshima; Sahoko Koyanagi; Tsutomu Shichino; Kazuhiko Fukuda
Journal:  Anesth Analg       Date:  2006-09       Impact factor: 5.108

2.  Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat.

Authors:  C R Neal; A Mansour; R Reinscheid; H P Nothacker; O Civelli; S J Watson
Journal:  J Comp Neurol       Date:  1999-04-19       Impact factor: 3.215

3.  Bidirectional modulatory effect of orphanin FQ on morphine-induced analgesia: antagonism in brain and potentiation in spinal cord of the rat.

Authors:  J H Tian; W Xu; Y Fang; J S Mogil; J E Grisel; D K Grandy; J S Han
Journal:  Br J Pharmacol       Date:  1997-02       Impact factor: 8.739

4.  In vitro and in vivo pharmacological characterization of J-113397, a potent and selective non-peptidyl ORL1 receptor antagonist.

Authors:  S Ozaki; H Kawamoto; Y Itoh; M Miyaji; T Azuma; D Ichikawa; H Nambu; T Iguchi; Y Iwasawa; H Ohta
Journal:  Eur J Pharmacol       Date:  2000-08-18       Impact factor: 4.432

5.  Spinal analgesic activity of orphanin FQ/nociceptin and its fragments.

Authors:  M A King; G C Rossi; A H Chang; L Williams; G W Pasternak
Journal:  Neurosci Lett       Date:  1997-02-21       Impact factor: 3.046

Review 6.  Neurobiology of nitrous oxide-induced antinociceptive effects.

Authors:  Masahiko Fujinaga; Mervyn Maze
Journal:  Mol Neurobiol       Date:  2002-04       Impact factor: 5.590

7.  Modification of nociception and morphine tolerance by the selective opiate receptor-like orphan receptor antagonist (-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol (SB-612111).

Authors:  Paola F Zaratin; Giuseppe Petrone; Massimo Sbacchi; Martine Garnier; Claudia Fossati; Paola Petrillo; Silvio Ronzoni; Giuseppe A M Giardina; Mark A Scheideler
Journal:  J Pharmacol Exp Ther       Date:  2003-10-30       Impact factor: 4.030

8.  Nociceptin/orphanin FQ and its receptor--potential targets for pain therapy?

Authors:  Hanns Ulrich Zeilhofer; Girolamo Calò
Journal:  J Pharmacol Exp Ther       Date:  2003-04-29       Impact factor: 4.030

9.  Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor.

Authors:  J C Meunier; C Mollereau; L Toll; C Suaudeau; C Moisand; P Alvinerie; J L Butour; J C Guillemot; P Ferrara; B Monsarrat
Journal:  Nature       Date:  1995-10-12       Impact factor: 49.962

10.  Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor.

Authors:  R K Reinscheid; H P Nothacker; A Bourson; A Ardati; R A Henningsen; J R Bunzow; D K Grandy; H Langen; F J Monsma; O Civelli
Journal:  Science       Date:  1995-11-03       Impact factor: 47.728

View more
  1 in total

1.  Antinociceptive effect of palm date spathe hydroalcoholic extract on acute and chronic pain in mice as compared with analgesic effect of morphine and diclofenac.

Authors:  Fatemeh Peyghambari; Mohammad Hossein Dashti-Rahmatabadi; Mansooreh Dehghanfi Rozabadi; Razieh Dehghanfi Rozabadi; Fatemeh Dehghanfi Rozabadi; Mohammadesmaeil Pangalizadeh; Narges Dehghanimohammadabadi
Journal:  Adv Biomed Res       Date:  2015-11-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.